CompletedNCT01878513
Genetic Testing to Guide Medication Choices for Psychosis
About this title
Read the official source — NCT01878513Medication studyAges 18–60United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- Glen OaksSee all locations and recruitment
Study information
Study start dateStarted: September 23, 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 88
- Sponsor
- Northwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT01878513
- Official title
Show the full official title
Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Glen Oaks
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Northwell Health.
Did this study involve medication?
Yes. The study involved medication, including risperidone.
Who was this study for?
Listed age limits: 18 years to 60 years.
